A SPIN-COVID-19 Cohort study led by team member Elsa-Lynn Nassar, which was recently published in The Lancet Rheumatology, found that 80% of participants used telehealth at least some of the time during the pandemic and that, post-pandemic, over 50% have continued to use at least some telehealth for their scleroderma care. An exception was in France, where only 35% received telehealth care in the pandemic and 20% post-pandemic. Check out the full article: https://www.thelancet.com/journals/lanrhe/article/PIIS2665-9913(24)00166-8/abstract